Study of molecular markers in patients with endometrial carcinoma and its prognosis on the effectiveness
GAO Xinping,ZHAO Lijun,SHEN Danhua,LI Xiaoping,WANG Jianliu,WEI Lihui
DOI: https://doi.org/10.13390/j.issn.1672-1861.2014.06.014
2014-01-01
Abstract:Objective To investigate the relationship between the expression of oncogene and cancer suppressor gene in the cancer tissue and the serum tumor markers with the clinic characters and the prognostic value of endometrial carcinoma.Methods 467 cases of endometrial cancer with complete data in the Peking University Peoples Hospital from Jan.1995 to Dec.2009 were enrolled.The tumor markers in the serum(CA125,CP2,CA199 and SA)and the expression of ER,PR,PTEN,p53 and Ki-67 in cancer tissues were detected.The correlation between the molecular markers and its clinical pathological characteristics and risk factors was analyzed.Results The expression of ER,PR,CA125,CP2 and PTEN was significantly different among the patients with different clinical pathological staging(P0.05).The expression of ER,PR,Ki-67 and SA was significantly different among that with different pathological classification(P0.05).The expression of PR,CA125 and CA199was significantly different among the patients with different depth of myometrial invasion(P0.05).The expression of ER,PR,CA125 and CP2was significantly different between the patients with or without lymph node metastasis(P0.05).The expression of CA125 and SA was significantly different between that with or without tumor thrombus in pulse tube(P0.05).The expression of CA125 was significantly different between that with or without ascites tumor cells(P0.05).The expression of PR in high risk group was significantly lower than that in low risk group(P0.05).The expression of Ki-67,CA125,CA199 and CP2were significantly higher in high risk group than that in low risk group(P0.05).There was no significantly different expression of ER,p53,PTEN and SA in two groups(P0.05). Conclusions The expresion of PR, Ki-67,CA125,CA199 and CP2 were closely related to the prognosis of endometrial cancer.